• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现氧化吴茱萸碱作为一种新型的微管聚合抑制剂和针对 LS-1034 细胞的抗结肠癌药物。

Discovery of oxyepiberberine as a novel tubulin polymerization inhibitor and an anti-colon cancer agent against LS-1034 cells.

机构信息

Department of Digestive Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

出版信息

Invest New Drugs. 2021 Apr;39(2):386-393. doi: 10.1007/s10637-020-01006-0. Epub 2020 Sep 30.

DOI:10.1007/s10637-020-01006-0
PMID:32997210
Abstract

Coptis chinensis Franch. has been extensively used in traditional Chinese medicine. The chemical structure of oxyepiberberine, as an alkaloid isolated from Coptis chinensis Franch., has been previously studied. However, anti-cancer effects and underlying mechanisms of oxyepiberberine need to be explored. This study aimed to investigate the anti-cancer effects and underlying mechanisms of oxyepiberberine on LS-1034 human colon cancer cells. The anti-proliferative effects of six derivatives of oxyepiberberine on colon cancer cells were assessed. Among six derivatives, oxyepiberberine showed the greatest anti-proliferative effect on LS-1034 cells with an IC value of 1.36 μM. Oxyepiberberine also induced apoptosis and inhibited migration of LS-1034 cells in a concentration-dependent manner. Importantly, oxyepiberberine was identified as a potent tubulin polymerization inhibitor. The tubulin polymerization inhibitory effects of oxyepiberberine in a concentration-dependent manner with an IC value of 1.26 μM were observed. A xenograft mouse model of colon cancer showed that oxyepiberberine could suppress tumor growth without an obvious toxicity. Conclusion Oxyepiberberine was found as a novel tubulin polymerization inhibitor, and it could be a promising agent to treat colon cancer.

摘要

黄连是一种在传统中药中广泛应用的植物。先前研究已经对黄连中分离得到的一种生物碱——小檗碱的化学结构进行了研究。然而,小檗碱的抗癌作用及其潜在机制仍需进一步探索。本研究旨在探讨小檗碱对 LS-1034 人结肠癌细胞的抗癌作用及其潜在机制。评估了小檗碱的六种衍生物对结肠癌细胞的增殖抑制作用。在这六种衍生物中,小檗碱对 LS-1034 细胞的增殖抑制作用最强,IC 值为 1.36 μM。小檗碱还能以浓度依赖性方式诱导 LS-1034 细胞凋亡和抑制迁移。重要的是,小檗碱被鉴定为一种有效的微管蛋白聚合抑制剂。小檗碱以浓度依赖性方式抑制微管蛋白聚合,IC 值为 1.26 μM。结肠癌的异种移植小鼠模型表明,小檗碱能抑制肿瘤生长而无明显毒性。结论小檗碱被发现是一种新型的微管蛋白聚合抑制剂,可能是治疗结肠癌的一种有前途的药物。

相似文献

1
Discovery of oxyepiberberine as a novel tubulin polymerization inhibitor and an anti-colon cancer agent against LS-1034 cells.发现氧化吴茱萸碱作为一种新型的微管聚合抑制剂和针对 LS-1034 细胞的抗结肠癌药物。
Invest New Drugs. 2021 Apr;39(2):386-393. doi: 10.1007/s10637-020-01006-0. Epub 2020 Sep 30.
2
Antitumor Activity of Asperphenin A, a Lipopeptidyl Benzophenone from Marine-Derived sp. Fungus, by Inhibiting Tubulin Polymerization in Colon Cancer Cells.海洋来源真菌 sp. 产生的脂肽苯甲酮 Asperphenin A 通过抑制结肠癌细胞微管蛋白聚合发挥抗肿瘤活性。
Mar Drugs. 2020 Feb 13;18(2):110. doi: 10.3390/md18020110.
3
Inhibition effect of oxyepiberberine isolated from Coptis chinensis franch. On non-small cell lung cancer based on a network pharmacology approach and experimental validation.基于网络药理学方法和实验验证的黄连中氧化小檗碱对非小细胞肺癌的抑制作用。
J Ethnopharmacol. 2021 Oct 5;278:114267. doi: 10.1016/j.jep.2021.114267. Epub 2021 Jun 1.
4
YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.YSL-12是一种新型的微管解聚剂,在体外和体内对结肠癌均具有强大的抗肿瘤活性。
Cancer Chemother Pharmacol. 2016 Jun;77(6):1217-29. doi: 10.1007/s00280-016-3036-4. Epub 2016 Apr 23.
5
Antitumor evaluation of novel phenothiazine derivatives that inhibit migration and tubulin polymerization against gastric cancer MGC-803 cells.新型吩噻嗪衍生物抑制胃癌 MGC-803 细胞迁移和微管聚合的抗肿瘤评价。
Invest New Drugs. 2019 Feb;37(1):188-198. doi: 10.1007/s10637-018-0682-x. Epub 2018 Oct 22.
6
Design, synthesis and antiproliferative evaluation of novel sulfanilamide-1,2,3-triazole derivatives as tubulin polymerization inhibitors.设计、合成及新型磺胺-1,2,3-三唑衍生物作为微管蛋白聚合抑制剂的抗增殖活性评价。
Invest New Drugs. 2018 Dec;36(6):1147-1157. doi: 10.1007/s10637-018-0632-7. Epub 2018 Jul 18.
7
An orally antitumor chalcone hybrid inhibited HepG2 cells growth and migration as the tubulin binding agent.一种口服抗肿瘤查尔酮杂合体作为微管结合剂抑制 HepG2 细胞生长和迁移。
Invest New Drugs. 2019 Aug;37(4):784-790. doi: 10.1007/s10637-019-00737-z. Epub 2019 Feb 11.
8
Ferulin C triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting Tubulin polymerization in vitro and in vivo.阿魏酸C通过在体外和体内抑制微管蛋白聚合,触发强效的PAK1和p21介导的乳腺癌抗肿瘤作用。
Pharmacol Res. 2020 Feb;152:104605. doi: 10.1016/j.phrs.2019.104605. Epub 2019 Dec 19.
9
Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4',5-trimethoxylstilbene-3'-O-phosphate disodium (M410).新型血管破坏剂(Z)-3,4',5-三甲氧基二苯乙烯-3'-O-磷酸二钠盐(M410)的抗肿瘤活性及其机制。
Invest New Drugs. 2011 Apr;29(2):300-11. doi: 10.1007/s10637-009-9366-x. Epub 2009 Dec 11.
10
Novel diaryl-2H-azirines: Antitumor hybrids for dual-targeting tubulin and DNA.新型二芳基-2H-氮杂环丁烷:用于双重靶向微管蛋白和 DNA 的抗肿瘤杂合体。
Eur J Med Chem. 2021 Mar 15;214:113256. doi: 10.1016/j.ejmech.2021.113256. Epub 2021 Feb 3.

引用本文的文献

1
Avermectin B1a Shows Potential Anti-Proliferative and Anticancer Effects in HCT-116 Cells via Enhancing the Stability of Microtubules.阿维菌素B1a通过增强微管稳定性对HCT-116细胞显示出潜在的抗增殖和抗癌作用。
Curr Issues Mol Biol. 2023 Jul 27;45(8):6272-6282. doi: 10.3390/cimb45080395.
2
Current Advances in for Gastrointestinal and Other Cancers.胃肠道及其他癌症的当前进展
Front Pharmacol. 2022 Jan 3;12:775084. doi: 10.3389/fphar.2021.775084. eCollection 2021.

本文引用的文献

1
Complete Chloroplast Genome Sequence of Franch. and Its Evolutionary History.毛脉柳叶菜(Franch.)的完整叶绿体基因组序列及其进化史
Biomed Res Int. 2017;2017:8201836. doi: 10.1155/2017/8201836. Epub 2017 Jun 18.